4//SEC Filing
Silvestro Stephen L 4
Accession 0001628280-25-009631
CIK 0001448431other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 9:18 AM ET
Size
8.9 KB
Accession
0001628280-25-009631
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Silvestro Stephen L
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-03-01+1,928→ 121,886 total - Tax Payment
Common Stock
2025-03-01$5.18/sh−572$2,963→ 121,314 total - Exercise/Conversion
Restricted Stock Units
2025-03-01−1,928→ 0 total→ Common Stock (1,928 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.
- [F2]These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
- [F3]The restricted stock units vested in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0001773461
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 9:18 AM ET
- Size
- 8.9 KB